Clinical Trial Update: Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and feasibility of autologous CD34+ hematopoietic stem cell mobilization and apheresis in participants with RUNX1 f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Runx1 Familial Platelet Disorder

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: RUNX1 Familial Platelet Disorder | Phase 1 | Status: RECRUITING